Laparoscopic Ablation Devices Market – Emerging Opportunities, Trends by Technology, Application, End-User, Region and Forecast Analysis (2022-2029)

Laparoscopic Ablation Devices Market was valued at US$ 5.26 Bn. in 2021, and the total laparoscopic ablation revenue is expected to grow at a CAGR of 9.6 % for the period 2022-2029, reaching nearly US$ 10.95 Bn. in 2029.

Laparoscopic Ablation Devices Market Overview:

The laparoscopic ablation device is a surgical diagnostic procedure used to examine the organs inside the abdomen and destroy tissues. The laparoscopic ablation procedure involves small incisions are made in the stomach and the belly is filled with air and small tubes containing tools are inserted through the cuts. One tube is equipped with a camera that sends images to a screen in the room. It will be used by the doctor to examine the area and remove patches. To remove the patches, a laser, electric current, gas, or another method will be used. The different techniques involved are laser ablation, electrocoagulation, and helica thermal coagulator, etc. Due to the presence of the benefits like low pain procedure, fast recovery rate and smaller incision, etc. are increasingly used in the operations of liver, pancreas, spleen, and pelvic. As a result, the global laparoscopic ablation device market is expected to reach US$ 10.95 Bn. by 2029.Laparoscopic Ablation Devices MarketTo know about the Research Methodology :- Request Free Sample Report

Laparoscopic Ablation Devices Market Dynamics:

The increasing rate of cancer in the globe and rising endometriosis disorder are driving the growth of the laparoscopic ablation devices market. According to “WORLD HEALTH ORGANIZATIONS (WHO)” cancer is the leading cause of death in 112 countries out of 183 countries. In 2021, MONGOLIA stood at first place by having the death rate of 210.72% due to cancer, followed by ARMENIA (197.93) and HUNGARY (175.46). Growing chronic diseases due to unhealthy diet conditions, smoking, drinking, and hypertension, and increasing demand for minimal invasive operation procedures are boosting the laparoscopic ablation devices market positively. Furthermore, increasing awareness among the people about its cost-saving procedures by the use of highly advanced technologies is aiding the market growth. In 2021, hospitals in the USA saved more than US$ 380 Mn by the use of these laparoscopic ablation devices. Growing technological development in medical science such as Sub-5 mm instruments, three-dimensional imaging, narrow-band imaging (NBI), and articulated instruments are among the new instruments reviewed. Smaller (mini-laparoscopy and percutaneous) instruments can achieve the same results as larger instruments while causing less abdominal wall trauma. Three-dimensional imaging may be especially beneficial for laparoscopic learners. The NBI may detect more endometriosis lesions, the clinical impact of the small increase in sensitivity appears to be insignificant when compared to conventional white light laparoscopy. By adding articulation to certain advanced energy devices, it may be possible to divide vascular pedicles that are difficult to reach with standard straight instruments. In 2021, The UCLA Department of Urology’s Division of Endourology and Minimally Invasive Surgery is collaborating with other specialists within the David Geffen School of Medicine at UCLA for developing novel biological sensors, instruments, and surgical techniques. This development helps in treating invasive surgery like kidney stones, live donor nephrectomy, pelvic organ prolapse, and prostate cancer, etc. Some of the factors slowing the growth of the laparoscopic ablation device market are the lack of awareness among the under developing and developing countries regarding its benefits such as low-cost treatment and less pain and availability of conventional medical treatments for cancer like chemotherapy and radiation therapy. Furthermore, with increasing side effects like abdominal pain and infection in the liver and the high cost of installation, the need for technologically experienced operators is becoming the roadblock for the growth of the Laparoscopic Ablation Devices market.

Laparoscopic Ablation Devices Market Segmentation:

Based on Technology, the Laparoscopic Ablation Devices Market is sub-segmented into radiofrequency ablation, thermal ablation, and cryoablation. The radiofrequency ablation segment dominates the global market and it held a share of 51 % in 2021. Also known as fulguration is a medical procedure that helps in stopping the pain signals by the use of the electric current in heating the small areas of nerve tissues. Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor in the globe, and its prevalence has been increasing day by day, this is the major factor anticipating the growth of radiofrequency ablation. In 2021, “AngioDynamics” was the leading manufacturer of medical equipment and introduced several devices like BioFlo PICC, NanoKnife 3.0 system, and Alpha Vac. As a result, the radiofrequency ablations segment is expected to grow at a CAGR of 3.1% during the forecast period. Based on End-User, the Laparoscopic Ablation Devices Market is sub-segmented into hospitals, ambulatory surgery centers, and specialty clinics. The ambulatory surgery center dominates the global market and was valued at US$ 2.1 Bn in 2021. Ambulatory surgery center ASCs provide services without the requirement of hospital admission. The people are attracting more towards the ASCs due to their cost-effective services, convenient environment, and less stress as compared to the hospitals. In 2021, according to the “US Department of Health and Human Services office” more than 98 % of the people were satisfied with the ASCs. The high level of professionalism, quality, and safety ASCs offer is an important reason patients and physicians choose ASCs for surgical procedures. As a result, the ambulatory surgery center is expected to grow at a CAGR of 22.9% by 2029.

Laparoscopic Ablation Devices Market regional insights:

In 2021, Asia-Pacific held the largest share in the laparoscopic ablation devices market. This increase is primarily due to an increase in the number of cancer patients and an increase in the aging population in the Asia-Pacific region. Growing demand for laparoscopic ablation devices from invasive surgeries, expansion of ambulatory surgery centers, and increased healthcare investment in this region are expected to drive market growth. Furthermore, rapidly developing economies such as China, India, Australia, and others are focusing on healthcare infrastructure, and several government initiatives throughout the Asia-Pacific region are increasing demand for the laparoscopic ablation market. For example, the Indian government has launched the "National Cancer Grid" initiative by investing US$ 147.72 Mn to ensure that every cancer patient receives consistent treatment. The objective of the report is to present a comprehensive analysis of the global Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Laparoscopic Ablation Devices Market dynamics, structure by analyzing the market segments and projecting the Laparoscopic Ablation Devices Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Laparoscopic Ablation Devices Market make the report investor’s guide.

Laparoscopic Ablation Devices Market Scope: Inquiry Before Buying

Global Laparoscopic Ablation Devices Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 5.26 Bn.
Forecast Period 2022 to 2029 CAGR: 9.6% Market Size in 2029: US $ 10.95 Bn.
Segments Covered: by Technology • Radiofrequency ablation • Thermal ablation • Cryoablation
by Application • Lung Cancer • Liver Cancer • Kidney Cancer • Bone Metastasis
by End-User • Hospitals • Ambulatory surgery center • Specialty clinics

Laparoscopic Ablation Devices Market, by Region

North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

Laparoscopic Ablation Devices Market Key Players

Boston scientific corporation • Edap tms • Medtronic • Misonix • Sonacare medical • Angiodynamics • Btg international ltd • Healthtronics, inc. • Mermaid medical, inc. • Neuwave medical, inc. • Coopersurgical inc. • Ethicon, inc. (johnson & johnson) • Olympus corp. • Richard wolf gmbh • Hologic, inc. • Minerva surgical, inc • Lumenis • Arthrex • Icecure • Merit medical Frequently Asked Questions: 1. Which region has the largest share in Laparoscopic Ablation Devices Market? Ans: Asia-Pacific held the largest share in 2021. 2. What is the growth rate of the Laparoscopic Ablation Devices Market? Ans: The Laparoscopic Ablation Devices Market is growing at a CAGR of 9.6 % during the forecasting period 2022-2029. 3. What segments are covered in Laparoscopic Ablation Devices Market? Ans: Laparoscopic Ablation Devices Market is segmented into technology, application and end-user. 4. What is the study period of this market? Ans: The Laparoscopic Ablation Devices Market is studied from 2021 to 2029. 5. Who are the key players in Fall Detection System Market? Ans: Boston scientific corporation, Edap tms, Medtronic, Misonix, Sonacare medical, Angiodynamics, Btg international ltd, Healthtronics, inc., Mermaid medical, inc., Neuwave medical, inc., Coopersurgical inc., Ethicon, inc. (johnson & johnson), Olympus corp., Richard wolf gmbh, Hologic, inc., Minerva surgical, inc, Lumenis, Arthrex, Icecure, Merit medical
1. Laparoscopic Ablation Devices Market: Research Methodology 2. Laparoscopic Ablation Devices Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Laparoscopic Ablation Devices Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Laparoscopic Ablation Devices Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Laparoscopic Ablation Devices Market Segmentation 4.1 Laparoscopic Ablation Devices Market, by technology (2021-2029) • Radiofrequency ablation • Thermal ablation • Cryoablation 4.2 Laparoscopic Ablation Devices Market, by application (2021-2029) • Lung Cancer • Liver Cancer • Kidney Cancer • Bone Metastasis 4.3 Laparoscopic Ablation Devices Market, by End-User (2021-2029) • Hospitals • Ambulatory surgery center • Specialty clinic 5. North America Laparoscopic Ablation Devices Market (2021-2029) 5.1 Laparoscopic Ablation Devices Market, by technology (2021-2029) • Radiofrequency ablation • Thermal ablation • Cryoablation 5.2 Laparoscopic Ablation Devices Market, by application (2021-2029) • Lung Cancer • Liver Cancer • Kidney Cancer • Bone Metastasis 5.3 Laparoscopic Ablation Devices Market, by End-User (2021-2029) • Hospitals • Ambulatory surgery center • Specialty clinic 5.4 North America Laparoscopic Ablation Devices Market, by Country (2021-2029) • United States • Canada • Mexico 6. Asia Pacific Laparoscopic Ablation Devices Market (2021-2029) 6.1. Asia Pacific Laparoscopic Ablation Devices Market, by technology (2021-2029) 6.2. Asia Pacific Laparoscopic Ablation Devices Market, by application (2021-2029) 6.3. Asia Pacific Laparoscopic Ablation Devices Market, by End-User (2021-2029) 6.4. Asia Pacific Laparoscopic Ablation Devices Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Laparoscopic Ablation Devices Market (2021-2029) 7.1 Middle East and Africa Laparoscopic Ablation Devices Market, by technology (2021-2029) 7.2. Middle East and Africa Laparoscopic Ablation Devices Market, by application (2021-2029) 7.3. Middle East and Africa Laparoscopic Ablation Devices Market, by End-User (2021-2029) 7.4. Middle East and Africa Laparoscopic Ablation Devices Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Laparoscopic Ablation Devices Market (2021-2029) 8.1. Latin America Laparoscopic Ablation Devices Market, by technology (2021-2029) 8.2. Latin America Laparoscopic Ablation Devices Market, by application (2021-2029) 8.3 Latin America Laparoscopic Ablation Devices Market, by End-User (2021-2029) 8.4. Latin America Laparoscopic Ablation Devices Market, by Country (2021-2029) • Brazil • Argentina • Rest Of Latin America 9. European Laparoscopic Ablation Devices Market (2021-2029) 9.1. European Laparoscopic Ablation Devices Market, by technology (2021-2029) 9.2. European Laparoscopic Ablation Devices Market, by application (2021-2029) 9.3. European Laparoscopic Ablation Devices Market, by End-User (2021-2029) 9.4. European Laparoscopic Ablation Devices Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Boston scientific corporation 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Edap tms 10.3 Medtronic 10.4 Misonix 10.5 Sonacare medical 10.6 Angiodynamics 10.7 Btg international ltd 10.8 Healthtronics, inc. 10.9 Mermaid medical, inc. 10.10 Neuwave medical, inc. 10.11 Coopersurgical inc. 10.12 Ethicon, inc. (johnson & johnson) 10.13 Olympus corp. 10.14 Richard wolf gmbh 10.15 Hologic, inc. 10.16 Minerva surgical, inc 10.17 Lumenis 10.18 Arthrex 10.19 Icecure 10.20 Merit medical
  • INQUIRE BEFORE BUYING